Your browser doesn't support javascript.
loading
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension.
Bigot, Pierre; Bernhard, Jean-Christophe; Khene, Zine-Eddine; Dariane, Charles; Lebdai, Souhil; Doumerc, Nicolas; Nouhaud, François Xavier; Ouzaid, Idir; Saulnier, Patrick; Méjean, Arnaud; Roupret, Morgan; Bensalah, Karim.
  • Bigot P; Department of Urology, Angers University Hospital, Angers, France.
  • Bernhard JC; Department of Urology, Bordeaux University Hospital, Bordeaux, France.
  • Khene ZE; Department of Urology, Rennes University Hospital, Rennes, France.
  • Dariane C; Department of Urology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Lebdai S; Department of Urology, Angers University Hospital, Angers, France.
  • Doumerc N; Department of Urology, CHU de Toulouse, Toulouse, France.
  • Nouhaud FX; Department of Urology, Rouen University Hospital, Rouen, France.
  • Ouzaid I; Department of Urology, Angers University Hospital, Paris, France.
  • Saulnier P; Department of Biostatistics, Angers University Hospital, Angers, France.
  • Méjean A; Department of Urology, Hôpital Européen Georges-Pompidou, Paris, France.
  • Roupret M; Department of Urology, Hôpital Pitié-Salpêtrière, Sorbonne Université, Paris, France.
  • Bensalah K; Department of Urology, Rennes University Hospital, Rennes, France.
BJU Int ; 132(5): 575-580, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37433580
OBJECTIVE: To evaluate prospectively the effects of surgical excision of renal tumours on blood pressure (BP). PATIENTS AND METHODS: In a multicentre prospective study, we evaluated 200 patients who underwent nephrectomy for renal tumour between 2018 and 2020 at seven departments of the French Network for Kidney Cancer, the UroCCR. All patients had localized cancer without pre-existing hypertension (HTN). Blood pressure was measured the week before nephrectomy, and at 1 month and 6 months after nephrectomy, according to the recommendations for home BP monitoring. Plasma renin was measured 1 week before surgery and 6 months after surgery. The primary endpoint was the occurrence of de novo HTN. The secondary endpoint was clinically significant increase in BP at 6 months, defined by an increase in systolic and/or diastolic ambulatory BP ≥10 mmHg or requirement for medical antihypertensive treatment. RESULTS: Blood pressure and renin measurements were available for 182 (91%) and 136 patients (68%), respectively. We excluded from the analysis 18 patients who had undeclared HTN detected on preoperative measurements. At 6 months, 31 patients (19.2%) had de novo HTN and 43 patients (26.3%) had a significant increase in their BP. Type of surgery was not associated with an increased risk of HTN (21.7% partial nephrectomy [PN] vs 15.7% radical nephrectomy [RN]; P = 0.59). There was no difference between plasmatic renin levels before and after surgery (18.5 vs 16; P = 0.46). In multivariable analysis, age (odds ratio [OR] 1.07, 95% confidence interval [CI] 1.02-1.12; P = 0.03) and body mass index (OR 1.14, 95% CI 1.03-1.26; P = 0.01) were the only predictors of de novo HTN. CONCLUSION: Surgical treatment of renal tumours is associated with significant changes in BP, with de novo HTN occurring in almost 20% of the patients. These changes are not impacted by the type of surgery (PN vs RN). Patients who are scheduled to undergo kidney cancer surgery should be informed of these findings and have their BP closely monitored after the operation.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Año: 2023 Tipo del documento: Article